Immunisation of male mice with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and t-helper epitopes suppresses fertility in vivo

M.A.H. Khan, V.A. Ferro, M. Koyama, Y. Kinugasa, M. Song, K. Ogita, Y. Murata, T. Kimura

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Immunisation against mammalian gonadotrophin releasing hormone (GnRH-I) linked to large carrier proteins has been shown to disrupt fertility. However, various studies have shown that the carrier protein causes epitope suppression of the hapten response, resulting in short-lived immunoneutralisation, followed by a return of fertility. A range of strategies has been used to resolve this, with limited success. The aim of this study was to construct a plasmid DNA vaccine encoding GnRH-I and T-helper epitopes. A 498 bp long vaccine construct in pcDNA3.1+ was administered to male mice in conjunction with a Hemagglutinating Virus of Japanese Envelop (HVJ-E) vector or in saline solution. The vaccine efficacy was evaluated in terms of GnRH-I specific IgG antibody response, serum testosterone levels, testicular spermatogenesis and the ability to produce offspring. The vaccine appeared to induce higher anti-GnRH-I IgG antibody response and insult the fertility axis, which was characterised by a drop of epididymal sperm counts, reduction of serum testosterone levels, suppressed testicular spermatogenesis and a significant decrease in litter numbers compared to control animals. The end-point vaccine efficacy was much higher in the HVJ-E vector mediated immunisation, than in saline alone.
LanguageEnglish
Pages3544-3553
Number of pages10
JournalVaccine
Volume25
Issue number18
DOIs
Publication statusPublished - 4 May 2007

Fingerprint

DNA Vaccines
recombinant vaccines
gonadotropin-releasing hormone
Gonadotropin-Releasing Hormone
epitopes
Fertility
Epitopes
Immunization
plasmids
immunization
Plasmids
vaccines
Vaccines
mice
transport proteins
spermatogenesis
testosterone
Spermatogenesis
Antibody Formation
Testosterone

Keywords

  • in vivo fertility
  • anti-GnRH-I antibody
  • GnRH-I vaccine

Cite this

Khan, M.A.H. ; Ferro, V.A. ; Koyama, M. ; Kinugasa, Y. ; Song, M. ; Ogita, K. ; Murata, Y. ; Kimura, T. / Immunisation of male mice with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and t-helper epitopes suppresses fertility in vivo. In: Vaccine. 2007 ; Vol. 25, No. 18. pp. 3544-3553.
@article{6691dd3008704596a10aa3e0f239f60e,
title = "Immunisation of male mice with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and t-helper epitopes suppresses fertility in vivo",
abstract = "Immunisation against mammalian gonadotrophin releasing hormone (GnRH-I) linked to large carrier proteins has been shown to disrupt fertility. However, various studies have shown that the carrier protein causes epitope suppression of the hapten response, resulting in short-lived immunoneutralisation, followed by a return of fertility. A range of strategies has been used to resolve this, with limited success. The aim of this study was to construct a plasmid DNA vaccine encoding GnRH-I and T-helper epitopes. A 498 bp long vaccine construct in pcDNA3.1+ was administered to male mice in conjunction with a Hemagglutinating Virus of Japanese Envelop (HVJ-E) vector or in saline solution. The vaccine efficacy was evaluated in terms of GnRH-I specific IgG antibody response, serum testosterone levels, testicular spermatogenesis and the ability to produce offspring. The vaccine appeared to induce higher anti-GnRH-I IgG antibody response and insult the fertility axis, which was characterised by a drop of epididymal sperm counts, reduction of serum testosterone levels, suppressed testicular spermatogenesis and a significant decrease in litter numbers compared to control animals. The end-point vaccine efficacy was much higher in the HVJ-E vector mediated immunisation, than in saline alone.",
keywords = "in vivo fertility, anti-GnRH-I antibody, GnRH-I vaccine",
author = "M.A.H. Khan and V.A. Ferro and M. Koyama and Y. Kinugasa and M. Song and K. Ogita and Y. Murata and T. Kimura",
year = "2007",
month = "5",
day = "4",
doi = "10.1016/j.vaccine.2007.01.089",
language = "English",
volume = "25",
pages = "3544--3553",
journal = "Vaccine",
issn = "0264-410X",
number = "18",

}

Immunisation of male mice with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and t-helper epitopes suppresses fertility in vivo. / Khan, M.A.H.; Ferro, V.A.; Koyama, M.; Kinugasa, Y.; Song, M.; Ogita, K.; Murata, Y.; Kimura, T.

In: Vaccine, Vol. 25, No. 18, 04.05.2007, p. 3544-3553.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Immunisation of male mice with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and t-helper epitopes suppresses fertility in vivo

AU - Khan, M.A.H.

AU - Ferro, V.A.

AU - Koyama, M.

AU - Kinugasa, Y.

AU - Song, M.

AU - Ogita, K.

AU - Murata, Y.

AU - Kimura, T.

PY - 2007/5/4

Y1 - 2007/5/4

N2 - Immunisation against mammalian gonadotrophin releasing hormone (GnRH-I) linked to large carrier proteins has been shown to disrupt fertility. However, various studies have shown that the carrier protein causes epitope suppression of the hapten response, resulting in short-lived immunoneutralisation, followed by a return of fertility. A range of strategies has been used to resolve this, with limited success. The aim of this study was to construct a plasmid DNA vaccine encoding GnRH-I and T-helper epitopes. A 498 bp long vaccine construct in pcDNA3.1+ was administered to male mice in conjunction with a Hemagglutinating Virus of Japanese Envelop (HVJ-E) vector or in saline solution. The vaccine efficacy was evaluated in terms of GnRH-I specific IgG antibody response, serum testosterone levels, testicular spermatogenesis and the ability to produce offspring. The vaccine appeared to induce higher anti-GnRH-I IgG antibody response and insult the fertility axis, which was characterised by a drop of epididymal sperm counts, reduction of serum testosterone levels, suppressed testicular spermatogenesis and a significant decrease in litter numbers compared to control animals. The end-point vaccine efficacy was much higher in the HVJ-E vector mediated immunisation, than in saline alone.

AB - Immunisation against mammalian gonadotrophin releasing hormone (GnRH-I) linked to large carrier proteins has been shown to disrupt fertility. However, various studies have shown that the carrier protein causes epitope suppression of the hapten response, resulting in short-lived immunoneutralisation, followed by a return of fertility. A range of strategies has been used to resolve this, with limited success. The aim of this study was to construct a plasmid DNA vaccine encoding GnRH-I and T-helper epitopes. A 498 bp long vaccine construct in pcDNA3.1+ was administered to male mice in conjunction with a Hemagglutinating Virus of Japanese Envelop (HVJ-E) vector or in saline solution. The vaccine efficacy was evaluated in terms of GnRH-I specific IgG antibody response, serum testosterone levels, testicular spermatogenesis and the ability to produce offspring. The vaccine appeared to induce higher anti-GnRH-I IgG antibody response and insult the fertility axis, which was characterised by a drop of epididymal sperm counts, reduction of serum testosterone levels, suppressed testicular spermatogenesis and a significant decrease in litter numbers compared to control animals. The end-point vaccine efficacy was much higher in the HVJ-E vector mediated immunisation, than in saline alone.

KW - in vivo fertility

KW - anti-GnRH-I antibody

KW - GnRH-I vaccine

U2 - 10.1016/j.vaccine.2007.01.089

DO - 10.1016/j.vaccine.2007.01.089

M3 - Article

VL - 25

SP - 3544

EP - 3553

JO - Vaccine

T2 - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 18

ER -